Prurigo Nodularis Treatment Market Structure Analysis

This Future Market Insights report examines the ‘Prurigo Nodularis Treatment Market’ for the period 2013–2017 and provides forecast for 2018–2028. The primary objective of the report is to offer updates and in-depth analysis of market opportunities in the global Prurigo Nodularis Treatment Market.

Globally, the increasing demand for Prurigo Nodularis treatment, for the treatment of rare diseases is anticipated to drive the growth prurigo nodularis treatment market over the forecast period. Increasing government spending on healthcare infrastructure such as favourable reimbursement for prurigo nodularis treatment is expected to boost growth of the global prurigo nodularis treatment market. The growing research initiatives for prurigo nodularis treatment with the help of non-profit organizations and increasing government support further fuel the growth of the Prurigo Nodularis Treatment Market.

However, availability of alternative treatment options and high treatment cost are the factors which are expected to hamper the growth of the global prurigo nodularis treatment market. Dearth of skilled healthcare professionals and lack of regulatory framework in emerging economics may further hinder the growth of the global Prurigo Nodularis Treatment Market over the forecast period.

Global Prurigo Nodularis Treatment Market has been segmented on the basis of:

• Product Type

• Distribution Channel

• Region

The report analyses global Prurigo Nodularis Treatment Market in terms of value (US$ Mn). Report begins with the market definition and explaining different product types which fall und prurigo nodularis treatment. The market view point section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro factors influencing global market for prurigo nodularis treatment. Opportunity analysis provided in the section allows client to better equip clients with crystal clear decision making insights.

The report analyses market based on regions and presents the forecast in terms of value for the next 10 years for prurigo nodularis treatment. Regions covered in the report include:

• North America

• Latin America

• Western Europe

• Eastern Europe

• Asia Pacific Excluding China and Japan (APECJ)

• China

• Japan

• Middle East and Africa (MEA)

Each of these section analyses regional market by product type, distribution channel, and country for prurigo nodularis treatment. Regional market dynamics section provides key growth trends pertaining to each region. Representative market participants section gives list of companies operating in every region, competitive landscape and intensity map of their presence in each region.

Weighted average selling price is considered to estimate the market size of various devices mentioned in the scope of the study. The country price is captured with the local currency. The local currency figures is then converted to USD to offer forecasts in a consistent currency standard. Furthermore, FMI also considered the latest annual exchange rate to reflect the impact of the most recent economic conditions of country. Prices considered in the models are standardized based on the average cost for Prurigo Nodularis treatment.

The forecast for prurigo nodularis treatment market presented in the report provides total revenue of Prurigo Nodularis treatment over 2018–2028. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report to the audiences with a dashboard view and to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to a market segments. Detailed profiles of players in Prurigo Nodularis Treatment Market are also provided in the report which highlights company description, overview, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of report analyses the market based on product type and presents the forecast in terms of value for the next 10 years. Prurigo Nodularis treatment product type covered in the report include:

• Corticosteroids

  • Injectable

  • Topical

  • Oral

• Emollients

• Capsacin Cream

• Antihistamines

• Others

The next section of report analyses the market based on distribution channel of the Prurigo Nodularis treatment and provides forecast in terms of value for the next 10 years. On the basis of distribution channel, the Prurigo Nodularis Treatment Market is segmented into:

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the products. To understand key growth segments, Future Market Insights provides the ‘Attractiveness Index’ analysis which helps client to identify real market opportunities.

Prurigo Nodularis Treatment And Management Market Reports - Table of Contents

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Prurigo Nodularis Product Type And Management Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Drivers

3.4. Restraints

3.5. Trends

4. Macroeconomic Assumptions

5. Global Economic Outlook

5.1. Expenditure on Health By Country, 2016-2021

5.2. Global Healthcare Market Outlook

6. North America Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028

6.1. Introduction

6.2. Historical Market Size (US$ Mn) By Country, 2013-2017

6.2.1. U.S.

6.2.2. Canada

6.3. Market Size (US$ Mn) Forecast By Country, 2018-2028

6.3.1. U.S.

6.3.2. Canada

6.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017

6.4.1. Corticosteroids

6.4.1.1. Injectable

6.4.1.2. Topical

6.4.1.3. Oral

6.4.2. Emollients

6.4.3. Capsaicin Cream

6.4.4. Antihistamines

6.4.5. Others

6.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

6.5.1. Corticosteroids

6.5.1.1. Injectable

6.5.1.2. Topical

6.5.1.3. Oral

6.5.2. Emollients

6.5.3. Capsaicin Cream

6.5.4. Antihistamines

6.5.5. Others

6.6. Others Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017

6.6.1. Hospital Pharmacies

6.6.2. Retail Pharmacies

6.6.3. Online pharmacies

6.7. Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028

6.7.1. Hospital Pharmacies

6.7.2. Retail Pharmacies

6.7.3. Online pharmacies

6.8. Market Attractiveness Analysis

6.8.1. By Country

6.8.2. By Product Type

6.8.3. By Distribution Channels

7. Latin America Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028

7.1. Introduction

7.2. Historical Market Size (US$ Mn) By Country, 2013-2017

7.2.1. Brazil

7.2.2. Mexico

7.2.3. Argentina

7.2.4. Rest of Latin America

7.3. Market Size (US$ Mn) Forecast By Country, 2018-2028

7.3.1. Brazil

7.3.2. Mexico

7.3.3. Argentina

7.3.4. Rest of Latin America

7.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017

7.4.1. Corticosteroids

7.4.1.1. Injectable

7.4.1.2. Topical

7.4.1.3. Oral

7.4.2. Emollients

7.4.3. Capsaicin Cream

7.4.4. Antihistamines

7.4.5. Others

7.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

7.5.1. Corticosteroids

7.5.1.1. Injectable

7.5.1.2. Topical

7.5.1.3. Oral

7.5.2. Emollients

7.5.3. Capsaicin Cream

7.5.4. Antihistamines

7.5.5. Others

7.6. Others Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017

7.6.1. Hospital Pharmacies

7.6.2. Retail Pharmacies

7.6.3. Online pharmacies

7.7. Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028

7.7.1. Hospital Pharmacies

7.7.2. Retail Pharmacies

7.7.3. Online pharmacies

7.8. Market Attractiveness Analysis

7.8.1. By Country

7.8.2. By Product Type

7.8.3. By Distribution Channels

8. Western Europe Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028

8.1. Introduction

8.2. Historical Market Size (US$ Mn) By Country, 2013-2017

8.2.1. Germany

8.2.2. U.K.

8.2.3. France

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Western Europe

8.3. Market Size (US$ Mn) Forecast By Country, 2018-2028

8.3.1. Germany

8.3.2. U.K.

8.3.3. France

8.3.4. Italy

8.3.5. Spain

8.3.6. Rest of Western Europe

8.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017

8.4.1. Corticosteroids

8.4.1.1. Injectable

8.4.1.2. Topical

8.4.1.3. Oral

8.4.2. Emollients

8.4.3. Capsaicin Cream

8.4.4. Antihistamines

8.4.5. Others

8.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

8.5.1. Corticosteroids

8.5.1.1. Injectable

8.5.1.2. Topical

8.5.1.3. Oral

8.5.2. Emollients

8.5.3. Capsaicin Cream

8.5.4. Antihistamines

8.5.5. Others

8.6. Others Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017

8.6.1. Hospital Pharmacies

8.6.2. Retail Pharmacies

8.6.3. Online pharmacies

8.7. Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028

8.7.1. Hospital Pharmacies

8.7.2. Retail Pharmacies

8.7.3. Online pharmacies

8.8. Market Attractiveness Analysis

8.8.1. By Country

8.8.2. By Product Type

8.8.3. By Distribution Channels

9. Eastern Europe Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028

9.1. Introduction

9.2. Historical Market Size (US$ Mn) By Country, 2013-2017

9.2.1. Russia

9.2.2. Poland

9.2.3. Rest of Eastern Europe

9.3. Market Size (US$ Mn) Forecast By Country, 2018-2028

9.3.1. Russia

9.3.2. Poland

9.3.3. Rest of Eastern Europe

9.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017

9.4.1. Corticosteroids

9.4.1.1. Injectable

9.4.1.2. Topical

9.4.1.3. Oral

9.4.2. Emollients

9.4.3. Capsaicin Cream

9.4.4. Antihistamines

9.4.5. Others

9.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

9.5.1. Corticosteroids

9.5.1.1. Injectable

9.5.1.2. Topical

9.5.1.3. Oral

9.5.2. Emollients

9.5.3. Capsaicin Cream

9.5.4. Antihistamines

9.5.5. Others

9.6. Others Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017

9.6.1. Hospital Pharmacies

9.6.2. Retail Pharmacies

9.6.3. Online pharmacies

9.7. Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028

9.7.1. Hospital Pharmacies

9.7.2. Retail Pharmacies

9.7.3. Online pharmacies

9.8. Market Attractiveness Analysis

9.8.1. By Country

9.8.2. By Product Type

9.8.3. By Distribution Channels

9.8.4. Drivers and Restraints: Impact Analysis

9.9. Market Attractiveness Analysis

9.9.1. By Country

9.9.2. By Product Type

9.9.3. By Distribution Channels

10. Asia Pacific Excluding China and Japan Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028

10.1.  Introduction

10.2.  Historical Market Size (US$ Mn) By Country, 2013-2017

10.2.1. India

10.2.2. Australia and New Zealand

10.2.3. ASEAN

10.2.4. Rest of APECJ

10.3.  Market Size (US$ Mn) Forecast By Country, 2018-2028

10.3.1. India

10.3.2. Australia and New Zealand

10.3.3. ASEAN

10.3.4. Rest of APECJ

10.4.  Historical Market Size (US$ Mn) By Product Type, 2013-2017

10.4.1. Corticosteroids

10.4.1.1. Injectable

10.4.1.2. Topical

10.4.1.3. Oral

10.4.2. Emollients

10.4.3. Capsaicin Cream

10.4.4. Antihistamines

10.4.5. Others

10.5.  Market Size (US$ Mn) Forecast By Product Type, 2018-2028

10.5.1. Corticosteroids

10.5.1.1. Injectable

10.5.1.2. Topical

10.5.1.3. Oral

10.5.2. Emollients

10.5.3. Capsaicin Cream

10.5.4. Antihistamines

10.5.5. Others

10.6.  Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017

10.6.1. Hospital Pharmacies

10.6.2. Retail Pharmacies

10.6.3. Online pharmacies

10.7.  Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028

10.7.1. Hospital Pharmacies

10.7.2. Retail Pharmacies

10.7.3. Online pharmacies

10.8.Market Attractiveness Analysis

10.8.1. By Country

10.8.2. By Product Type

10.8.3. By Distribution Channels

11. China Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028

11.1. Introduction

11.2. Historical Market Size (US$ Mn) By Product Type, 2013-2017

11.2.1. Corticosteroids

11.2.1.1. Injectable

11.2.1.2. Topical

11.2.1.3. Oral

11.2.2. Emollients

11.2.3. Capsaicin Cream

11.2.4. Antihistamines

11.2.5. Others

11.3. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

11.3.1. Corticosteroids

11.3.1.1. Injectable

11.3.1.2. Topical

11.3.1.3. Oral

11.3.2. Emollients

11.3.3. Capsaicin Cream

11.3.4. Antihistamines

11.3.5. Others

11.4. Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017

11.4.1. Hospital Pharmacies

11.4.2. Retail Pharmacies

11.4.3. Online pharmacies

11.5. Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028

11.5.1. Hospital Pharmacies

11.5.2. Retail Pharmacies

11.5.3. Online pharmacies

11.6.Market Attractiveness Analysis

11.6.1. By Product Type

11.6.2. By Distribution Channels

12. Japan Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028

12.1.Introduction

12.2.Historical Market Size (US$ Mn) By Product Type, 2013-2017

12.2.1. Corticosteroids

12.2.1.1. Injectable

12.2.1.2. Topical

12.2.1.3. Oral

12.2.2. Emollients

12.2.3. Capsaicin Cream

12.2.4. Antihistamines

12.2.5. Others

12.3.Market Size (US$ Mn) Forecast By Product Type, 2018-2028

12.3.1. Corticosteroids

12.3.1.1. Injectable

12.3.1.2. Topical

12.3.1.3. Oral

12.3.2. Emollients

12.3.3. Capsaicin Cream

12.3.4. Antihistamines

12.3.5. Others

12.4.Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017

12.4.1. Hospital Pharmacies

12.4.2. Retail Pharmacies

12.4.3. Online pharmacies

12.5.Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028

12.5.1. Hospital Pharmacies

12.5.2. Retail Pharmacies

12.5.3. Online pharmacies

12.6.Market Attractiveness Analysis

12.6.1. By Product Type

12.6.2. By Distribution Channels

13. Middle East and Africa Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028

13.1.Introduction

13.2.Historical Market Size (US$ Mn) By Country, 2013-2017

13.2.1. GCC Countries

13.2.2. South Africa

13.2.3. Rest of Middle East and Africa

13.3.Market Size (US$ Mn) Forecast By Country, 2018-2028

13.3.1. GCC Countries

13.3.2. South Africa

13.3.3. Rest of Middle East and Africa

13.4.Historical Market Size (US$ Mn) By Product Type, 2013-2017

13.4.1. Corticosteroids

13.4.1.1. Injectable

13.4.1.2. Topical

13.4.1.3. Oral

13.4.2. Emollients

13.4.3. Capsaicin Cream

13.4.4. Antihistamines

13.4.5. Others

13.5.Market Size (US$ Mn) Forecast By Product Type, 2018-2028

13.5.1. Corticosteroids

13.5.1.1. Injectable

13.5.1.2. Topical

13.5.1.3. Oral

13.5.2. Emollients

13.5.3. Capsaicin Cream

13.5.4. Antihistamines

13.5.5. Others

13.6.Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017

13.6.1. Hospital Pharmacies

13.6.2. Retail Pharmacies

13.6.3. Online pharmacies

13.7.Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028

13.7.1. Hospital Pharmacies

13.7.2. Retail Pharmacies

13.7.3. Online pharmacies

13.8.Market Attractiveness Analysis

13.8.1. By Country

13.8.2. By Product Type

13.8.3. By Distribution Channels

14. Forecast Factors: Relevance and Impact

15. Competition Landscape

15.1.Competition Dashboard

15.2.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

15.2.1. Bayer AG

15.2.2. Pfizer Inc.

15.2.3. GlaxoSmithKline plc.

15.2.4. Teva Pharmaceutical Industries Ltd

15.2.5. Johnson & Johnson Services, Inc.

15.2.6. Merck & Co. Inc.

15.2.7. Sanofi SA

15.2.8. Takeda Pharmaceutical Company Limited

16. Global Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028 By Region

16.1.Introduction / Key Findings

16.2.Historical Market Size (US$ Mn) By Region

16.2.1. North America

16.2.2. Western Europe

16.2.3. Eastern Europe

16.2.4. Latin America

16.2.5. Asia Pacific Excluding China and Japan

16.2.6. China

16.2.7. Japan

16.2.8. Middle East and Africa

16.3.Market Size (US$ Mn) Forecast By Region

16.3.1. North America

16.3.2. Western Europe

16.3.3. Eastern Europe

16.3.4. Latin America

16.3.5. Asia Pacific Excluding China and Japan

16.3.6. China

16.3.7. Japan

16.3.8. Middle East and Africa

16.4.Market Attractiveness Analysis By Region

17. Global Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028, By Product Type

17.1.Introduction/Key Finding

17.2.Historical Market Size (US$ Mn) By Product Type, 2013-2017

17.2.1. Corticosteroids

17.2.1.1. Injectable

17.2.1.2. Topical

17.2.1.3. Oral

17.2.2. Emollients

17.2.3. Capsaicin Cream

17.2.4. Antihistamines

17.2.5. Others

17.3.Others Market Size (US$ Mn) Forecast By Product Type, 2018-2028

17.3.1. Corticosteroids

17.3.1.1. Injectable

17.3.1.2. Topical

17.3.1.3. Oral

17.3.2. Emollients

17.3.3. Capsaicin Cream

17.3.4. Antihistamines

17.3.5. Others

17.4.Market Attractiveness Analysis By Product Type

18. Global Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028, By Distribution Channels

18.1.Introduction/Key Finding

18.2.Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017

18.2.1. Hospital Pharmacies

18.2.2. Retail Pharmacies

18.2.3. Online pharmacies

18.3.Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028

18.3.1. Hospital Pharmacies

18.3.2. Retail Pharmacies

18.3.3. Online pharmacies

18.4.Market Attractiveness Analysis By Distribution Channels

19. Global Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028

19.1.Market Size and Y-o-Y Growth

19.2.Absolute $ Opportunity

20. Assumptions and Acronyms Used

21. Research Methodology